Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for Psychological Distress in Advanced Gastrointestinal Cancers
NCT05220046Phase 1Completed
- Sponsor
- University of Nebraska
- Start
- Apr 2023
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 1, open-label trial of psilocybin in psychological distress (2 arms), sponsored by University of Nebraska. Primary endpoints: Recruitment Rate at 18 months and Retention Rate at 24 months. Started Apr 2023; status: completed.
02
Drugs
psilocybin
03
Conditions
psychological distress
Beyond the preview
Go deeper on NCT05220046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05220046.